No Matches Found
No Matches Found
No Matches Found
Why is Vimta Labs falling/rising?
As of 20-Nov, Vimta Labs Ltd's stock price is at 619.40, down 0.98%, and has underperformed the Sensex recently. Despite this short-term decline, the stock has strong long-term growth, with a year-to-date increase of 24.50% and a 66.67% rise over the past year, indicating it remains a hold for investors.
Why is Vimta Labs falling/rising?
As of 07-Nov, Vimta Labs Ltd is seeing a price increase to 655.95, up 5.47%, after three days of decline. Despite recent short-term challenges, the stock has strong long-term growth potential, with a 127.54% increase over the past year and solid financial health.
Why is Vimta Labs falling/rising?
As of 06-Nov, Vimta Labs Ltd's stock price is Rs 621.95, down 5.96% today and 14.24% over the last three days, underperforming its sector. However, it has a strong long-term growth outlook with a 113.36% increase over the past year and a favorable year-to-date return of 25.02%.
How has been the historical performance of Vimta Labs?
Vimta Labs' historical performance shows mixed results, with net sales decreasing to 288.60 Cr in March 2024 from 318.19 Cr in March 2023, while profit after tax increased to 48.81 Cr. Total assets rose to 392.25 Cr, but cash flow from operating activities fell to 60.00 Cr, resulting in a net cash outflow of 17.00 Cr.
Are Vimta Labs latest results good or bad?
Vimta Labs' Q2 FY26 results are strong, with a net profit of ₹15.25 crores (up 140.92% year-on-year) and revenue of ₹84.74 crores (up 29.30 year-on-year), alongside improved operating margins. However, the stock price declined due to profit-taking after a significant rally, despite the company's solid performance and debt-free status.
Vimta Labs Q2 FY26: Stellar 141% Profit Surge Masks Valuation Concerns
Vimta Labs Ltd., India's comprehensive contract research and testing organisation, delivered a blockbuster second quarter for fiscal year 2026, with consolidated net profit surging 140.92% year-on-year to ₹15.25 crores, up from ₹6.33 crores in Q2 FY25. The Hyderabad-based healthcare services provider, commanding a market capitalisation of ₹3,166 crores, demonstrated robust operational momentum with revenue climbing 29.30% YoY to ₹84.74 crores, marking one of its strongest quarterly performances in recent years.
When is the next results date for Vimta Labs?
Vimta Labs will announce its results on 03 November 2025.
Why is Vimta Labs falling/rising?
As of 15-Oct, Vimta Labs Ltd's stock price is Rs 699.00, up 1.6%, with a strong long-term performance of 154.64% over the past year despite a recent negative return of -11.57%. The company shows solid financial health and has outperformed the broader market significantly over various periods.
Is Vimta Labs technically bullish or bearish?
As of October 10, 2025, Vimta Labs shows a mildly bullish trend supported by bullish MACD and Bollinger Bands, but tempered by a mildly bearish Dow Theory signal and a lack of momentum confirmation from the RSI.
Vimta Labs Shows Mixed Technical Trends Amidst Significant Market Performance Gains
Vimta Labs, a small-cap healthcare services company, has experienced stock price fluctuations, currently at 713.40. The stock has shown impressive annual returns of 161.27% and a three-year return of 326.16%, significantly outperforming the Sensex. Technical indicators present a mixed outlook amid recent market evaluations.
Is Vimta Labs technically bullish or bearish?
As of October 10, 2025, Vimta Labs shows a mildly bullish trend supported by positive MACD and moving averages, but caution is advised due to a mildly bearish Dow Theory signal and lack of momentum in the RSI.
Is Vimta Labs technically bullish or bearish?
As of October 10, 2025, Vimta Labs shows a mildly bullish trend supported by bullish MACD and moving averages, though tempered by a mildly bearish Dow Theory signal and lack of momentum confirmation from the RSI.
Why is Vimta Labs falling/rising?
As of 24-Sep, Vimta Labs Ltd's stock price is Rs 730.60, down 2.54% after three consecutive days of decline totaling 11.4%. Despite strong long-term growth, recent underperformance and reduced investor participation are impacting sentiment.
Why is Vimta Labs falling/rising?
As of 23-Sep, Vimta Labs Ltd's stock price is Rs 749.65, down 1.92%, with a recent two-day loss of 8.99%. Despite short-term setbacks, the company has shown strong long-term growth potential, evidenced by a 165.60% return over the past year and consistent positive quarterly results.
Why is Vimta Labs falling/rising?
As of 22-Sep, Vimta Labs Ltd's stock price has declined to Rs 764.30, down 7.31%, underperforming its sector. Despite this short-term drop, the stock has shown strong long-term growth with a 171.82% increase over the past year.
Vimta Labs Faces Volatility Amid Broader Market Decline and Trend Reversal Signals
Vimta Labs, a small-cap healthcare services company, saw a significant decline on September 22, 2025, following a three-day gain streak. The stock's performance lagged behind its sector, and despite today's drop, it remains above several key moving averages. The broader market also opened lower, reflecting overall market trends.
Why is Vimta Labs falling/rising?
As of 19-Sep, Vimta Labs Ltd is currently priced at 824.60, reflecting a 3.87% increase and strong performance with a 5.04% rise over the past week. Despite impressive long-term growth and outperformance against the Sensex, a decline in investor participation may raise concerns for future trading activity.
Why is Vimta Labs falling/rising?
As of 18-Sep, Vimta Labs Ltd is currently priced at 793.90, reflecting a 1.08% increase. The stock has shown strong long-term performance with a 177.85% rise over the past year, despite a recent decline in investor participation.
Why is Vimta Labs falling/rising?
As of 17-Sep, Vimta Labs Ltd is currently priced at Rs 785.45, reflecting a 1.18% increase and an 18.94% rise over the past month. Despite a decline in delivery volume, the stock's strong fundamentals and historical performance indicate a positive outlook.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
